Doctor profile · Federal record

Dr. Madeline McKenna, APRN

Family Nurse Practitioner (CMS: Nurse Practitioner) · Registered Nurse · Registered Nurse · Family Nurse Practitioner · North Andover, MA

  • NPI 1841829926
  • Accepts Medicare
  • MIPS 76.0 / 100 · 2023
  • 6 yrs in practice
  • Licensed in 3 states
  • Female
  • Solo practice
  • No sanctions

Practice & contact

Operates at 3 locations .

NPPES Updated May 11, 2026
Primary practice
565 Turnpike St Ste 85
North Andover, MA 018455936
(978) 689-2247
Additional location
590 Court St
Keene, NH 034311719
(603) 354-5400
Additional location
71 Washington St
Brighton, MA 021354301
(888) 502-4571

Credentials & registration

NPPES · NUCC
NPI registered
April 2020 — 6 yrs on file
Profile last updated
December 10, 2024
Year of graduation
2020 — 6 yrs since
Specialty taxonomy
363LF0000X — NUCC code
State licenses (3)
Massachusetts #RN2333579 · Connecticut #153652 · New Hampshire #083576-23

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1841829926. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
362
Distinct HCPCS
6
Medicare allowed
$35,397
HCPCS Description Services Patients Avg allowed
80307 Testing for presence of drug, by chemistry analyzers 105 49 $61
99213 Established patient office or other outpatient visit, 20-29 minutes 102 44 $66
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms 49 27 $153
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes 43 11 $102
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms 38 22 $195
99214 Established patient office or other outpatient visit, 30-39 minutes 25 15 $120

In context: peer comparison

Among 9 peers in this city , average services per provider: 108. This provider delivers 3.4× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$28
Transactions
1
Manufacturers
1
Payer (manufacturer) Industry Txns Amount
Actelion Pharmaceuticals US, Inc. 1 $27.52

By nature of payment

Food and Beverage
$28

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
331
Patients
75
Total drug cost
$42,303
Drug Type Claims Patients Total cost
Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl) Brand 220 64 $26,038
Suboxone (Buprenorphine Hcl/Naloxone Hcl) Brand 40 11 $15,107
Buprenorphine Hcl Generic 33 0 $663
Losartan Potassium Generic 14 0 $239
Clopidogrel (Clopidogrel Bisulfate) Brand 13 0 $179
Metoprolol Tartrate Generic 11 0 $77

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Madeline McKenna's medical specialty?
Dr. Madeline McKenna practices Family Nurse Practitioner in North Andover, MA.
Where does Dr. Madeline McKenna practice?
Dr. Madeline McKenna practices at 565 Turnpike St Ste 85, North Andover, MA 018455936. Office phone: 9786892247.
What is Dr. Madeline McKenna's NPI?
Dr. Madeline McKenna's National Provider Identifier (NPI) is 1841829926, issued by NPPES.
Does Dr. Madeline McKenna accept Medicare assignment?
Yes. Dr. Madeline McKenna accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Madeline McKenna commonly perform?
Top Medicare-reported procedures in 2023: Testing for presence of drug, by chemistry analyzers (HCPCS 80307); Established patient office or other outpatient visit (HCPCS 99213); Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS G0481). Source: CMS Medicare Physician & Other Practitioners file.